Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth - Archive ouverte HAL Access content directly
Journal Articles Cell Reports Year : 2021

Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth

(1) , (1) , (2) , (1) , (1) , (3) , (1) , (1) , (1) , (1) , (1) , (1) , (4) , (5) , (5) , (5) , (4) , (6) , (5) , (7) , (2) , (1) , (7, 1) , (1)
1
2
3
4
5
6
7
Michela Notarangelo
Shintaro Aibara
Alessia Soldano
Valentina Adami
Chiara Ambrosini
Francesca Broso
Sara Longhi
Alessandro Quattrone

Abstract

Glioblastoma stem cells (GSCs) resist current glioblastoma (GBM) therapies. GSCs rely highly on oxidative phosphorylation (OXPHOS), whose function requires mitochondrial translation. Here we explore the therapeutic potential of targeting mitochondrial translation and report the results of high-content screening with putative blockers of mitochondrial ribosomes. We identify the bacterial antibiotic quinupristin/dalfopristin (Q/D) as an effective suppressor of GSC growth. Q/D also decreases the clonogenicity of GSCs in vitro, consequently dysregulating the cell cycle and inducing apoptosis. Cryoelectron microscopy (cryo-EM) reveals that Q/D binds to the large mitoribosomal subunit, inhibiting mitochondrial protein synthesis and functionally dysregulating OXPHOS complexes. These data suggest that targeting mitochondrial translation could be explored to therapeutically suppress GSC growth in GBM and that Q/D could potentially be repurposed for cancer treatment.

Dates and versions

hal-03565947 , version 1 (11-02-2022)

Identifiers

Cite

Denise Sighel, Michela Notarangelo, Shintaro Aibara, Angela Re, Gianluca Ricci, et al.. Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth. Cell Reports, 2021, 35 (4), pp.109024. ⟨10.1016/j.celrep.2021.109024⟩. ⟨hal-03565947⟩
15 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More